Affordable Access

deepdyve-link
Publisher Website

Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.

Authors
  • Evans, Marie1
  • Carrero, Juan-Jesus1, 2
  • Bellocco, Rino3, 4
  • Barany, Peter1
  • Qureshi, Abdul R1
  • Seeberger, Astrid1
  • Jacobson, Stefan H5
  • Hylander-Rössner, Britta1
  • Rotnitzky, Andrea6
  • Sjölander, Arvid3
  • 1 CLINTEC Renal Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. , (Sweden)
  • 2 Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. , (Sweden)
  • 3 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. , (Sweden)
  • 4 Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy. , (Italy)
  • 5 Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden. , (Sweden)
  • 6 University Di Tella and CONICET, Buenos Aires, Argentina. , (Argentina)
Type
Published Article
Journal
Nephrology Dialysis Transplantation
Publisher
Oxford University Press
Publication Date
Nov 01, 2017
Volume
32
Issue
11
Pages
1892–1901
Identifiers
DOI: 10.1093/ndt/gfw328
PMID: 27672090
Source
Medline
Keywords
License
Unknown

Abstract

In non-dialysis patients with CKD, ESA initiation at Hb < 10.0-11.0 g/dL is associated with improved survival in patients otherwise treated according to guidelines.

Report this publication

Statistics

Seen <100 times